Ticker Details
AbCellera Biologics Inc.
IPO Date:	December 11, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$909.98M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.36 | 3.11%
Avg Daily Range (30 D):	$0.15 | 4.02%
Avg Daily Range (90 D):	$0.13 | 3.23%

Institutional Daily Volume
Avg Daily Volume:	2.42M
Avg Daily Volume (30 D):	4.33M
Avg Daily Volume (90 D):	4.15M

Trade Size
Avg Trade Size (Sh.):	168
Avg Trade Size (Sh.) (30 D):	241
Avg Trade Size (Sh.) (90 D):	226

Institutional Trades
Total Institutional Trades:	1,321
Avg Institutional Trade:	$1.77M
Avg Institutional Trade (30 D):	$.74M
Avg Institutional Trade (90 D):	$.88M
Avg Institutional Trade Volume:	.17M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.94M
Avg Closing Trade (30 D):	$.64M
Avg Closing Trade (90 D):	$.72M
Avg Closing Volume:	199.15K

News

Aug 14, 2025 @ 11:23 AM Prelude Cuts Q2 Losses and Costs 13% Source: Jesterai

Jul 30, 2025 @ 5:00 PM Global Antibody Discovery Market to Observe Stupen... Source: Delveinsight

Jun 13, 2024 @ 9:40 AM Down 57%, Is AbCellera Biologics a Buy on the Dip?... Source: newsfeedback@fool.com (Cory Renauer)

May 8, 2024 @ 8:30 AM AbCellera Biologics (ABCL) Q1 2024 Earnings Call T... Source: newsfeedback@fool.com (Motley Fool Transcribing)

May 7, 2024 @ 10:05 PM AbCellera Biologics Inc. (ABCL) Reports Q1 Loss, M... Source: Zacks Equity Research

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS		$-.19	$-.12
Diluted EPS		$-.19	$-.12
Revenue		$8.96M	$17.08M
Gross Profit
Net Income / Loss		$-57.12M	$-34.73M
Operating Income / Loss		$-76.28M	$-49.59M
Cost of Revenue
Net Cash Flow		$-9.28M	$-66.83M
PE Ratio